Authors
Loading...
Retrospective study assesses tumor-infiltrating lymphocytes as a marker of recurrence risk in stage II colon cancer, suggesting clinical application.
Dhouha et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: